Detalhe da pesquisa
1.
Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19.
Front Immunol
; 13: 881604, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664008
2.
Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models.
PLoS One
; 17(8): e0269823, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998134
3.
Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease.
Sci Rep
; 12(1): 10359, 2022 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725862